Ironwood Pharmaceuticals | IRWD - 销售成本

股票价格
4.73
每天变化
0.06 1.28%
每月一次
36.71%
每年
497.22%
Q2 预测
4.35


金融业
股票价格
USD
资产
USD 396.06M
现金及等价物
USD 140.41M
销售成本
USD 29.83M
流动资产
USD 273.84M
流动负债
USD 242.5M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD -0.01
股本和储备
USD -264.16M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 731M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
204.24
税前利润
USD 68.02M
销售收入
USD 47.71M
销售和管理费用
USD 33.33M
贸易债权人
USD 1.61M
应收帐款人
USD 81.89M


销售成本 更改 日
Acadia Pharmaceuticals USD 26.22M 4.58M 2025-12
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Akebia Therapeutics USD 10.34M 441K 2025-12
Almirall EUR 191.5M 2.29M 2025-12
Alnylam Pharmaceuticals USD 211.12M 56.6M 2026-03
Amarin USD 26.05M 1.41M 2025-12
Ardelyx USD 10.85M 6.87M 2025-12
Astellas Pharma JPY 129.43B 19.7B 2026-03
AstraZeneca USD -204M 3.48B 2026-03
Charles River Laboratories USD 722.27M 28.81M 2025-12
Coherus Biosciences USD 4.04M 324K 2025-12
Emergent BioSolutions USD 381.2M 226.1M 2023-06
Esperion Therapeutics USD 27.85M 13.43M 2025-12
Halozyme Therapeutics USD 102.15M 29.14M 2025-12
Incyte USD 104.5M 16.68M 2026-03
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Lexicon Pharmaceuticals USD 201K 191K 2025-12
MacroGenics USD 10.12M 34.18M 2025-12
Moderna USD 955M 503M 2026-03
Myriad Genetics USD 63M 1.1M 2025-12
Pacira USD 50.74M 3.89M 2026-03
PTC Therapeutics USD 16.3M 7.02M 2025-12
Puma Biotechnology USD 29.1M 18.44M 2024-09
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
Takeda JPY 401.15B 184.07B 2025-12
Ultragenyx Pharmaceutical USD 30M 1000K 2026-03
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12